ADCYAP1 and migraine disorder: Al-Khazali et al. show in a randomized, double-blind, placebo-controlled trial that intravenous infusion of PACAP-38 is a potent inducer of migraine-like headache in people with persistent post-traumatic headache (PTH) resulting from mild traumatic brain injury.